SENSEX    73651.35       655.04    |    NIFTY    22326.9       203.25 FAQ    |    Feedback
EQUITIES
DERIVATIVES
IPO
Gainers & Losers Value & Volume Toppers 52 Weeks High/Low Advances & Declines
New High-Low
Pre-Session Mid-Session End-Session Other Markets Market Beat Stock Alert
Hot Pursuit Foreign Markets Economy News Corporate News Corporate Results
Detailed Quotes Board of Directors Balance Sheet Profit & Loss Quarterly Results Historical Price
Financial Ratios Company Background Technical Chart
Announcements Book Closure Board Meetings Bonus Issues Rights Issues
De-Listed Shares Name Change Split of Face Value Market Turnover
FII Investments MF Investments ADR Prices World Indices
Forthcoming IPOs
Open IPOs
Closed IPOs
New Listing
Basis Of Allotment Draft Prospectus New Issue Monitor
Get Quotes
Gainers
Losers
Value Toppers Advances & Declines Ticker Spot
Ticker Futures Closing Price Technical Chart Commodity News MCX Currency Futures
Get Quotes NIFTY Futures Top Traded Value Top Quantity Most Active Contracts
FII Statistics Daily Settlement Price List of Underlyings Put Call Ratio Derivative Summary
All Index Futures Top Gainers Top Losers Most Active Put Most Active Call
Highest in OI Lowest in OI Increase in OI Decrease in OI
Stock Alert
Overall view of all the recent market developments which will help in your investment decisions
Mazagon Dock, UTI AMC, Vedanta in spotlight
12-Oct-20   08:23 Hrs IST

Shares of Mazagon Dock Shipbuilders will debut on the bourses today, 12 October 2020. The issue price is fixed at Rs 145 per share.

Shares of UTI Asset Management Company (AMC) debut on the bourses today, 12 October 2020. The issue price is fixed at Rs 554 per share.

Vedanta said that in connection with the delisting offer, Vedanta Resources and its indirect subsidiaries namely, Vedanta Holdings Mauritius and Vedanta Holdings Mauritius II, that the delisting offer is deemed to have failed in terms of Regulation 19(1) of the delisting regulations.

Glenmark Pharmaceuticals announced results of its “FAITH” combination trial with antivirals Umifenovir and Favipiravir for the treatment of moderate hospitalized COVID-19 patients. This was the second clinical study after the successful Favipiravir monotherapy trial earlier this year that led the company to receiving the Emergency Use Authorisation for Favipiravir. This second study titled the FAITH trial evaluated the possible superiority of the combination's efficacy against Favipiravir monotherapy. As per the results that Glenmark presented to the regulator, the study showed no superior clinical outcomes with the addition of Umifenovir.

RITES announced that it has secured consultancy orders worth Rs 103 crore from various clients.

Federal-Mogul Goetze (India) said that promoter entity IEH FMGI Holdings LLC proposes to sell up to 1,21,45,391 equity shares (representing 21.83% of the paid-up equity) through offer for sale on October 12-13. The floor price has been fixed at Rs 342 per share.

Karnataka Bank on Friday (9 October) declared its exposure of Rs 107.99 crore to Sintex Industries (SIL) as fraud. In 2016, SIL had availed various credit facilities under consortium arrangement wherein, Karnataka Bank was one of the fifteen member banks. Karnataka Bank's total exposure in the arrangement stood at around 1.74%.

Indiabulls Housing Finance has further sold a portion of its stake in OakNorth Holding (the wholly owning parent company of OakNorth Bank) (OakNorth), to Riva Capital Partners V, L.P., USA, for approximately Rs 441 crore. The sale proceeds will be accretive to the regulatory net worth and the CRAR of the company.

Premier Explosives on Friday (9 October) said it received a Rs 82.83 crore order from state-run Singareni Collieries Company in Telangana for supplying SMS/SME explosives and accessories.

Great Eastern Shipping Company on Friday (9 October) said it signed a contract to buy a secondhand LR2 product carrier of about 105,258 deadweight tonnage (dwt). The 2012 South Korean built vessel is expected to join the company's fleet in Q3 FY21.

JBM Auto has entered into share purchase agreement with Sandhar Technologies to purchase the remaining 50% stake in INDO Toolings. JBM Auto will purchase 2 lakh equity shares, or 50% equity, of INDO Toolings at Rs 14.65 each, aggregating to Rs 29.30 lakh. The transaction is at arm's length basis. The promoters & promoters group are in no way interested in the transaction.

Shilpa Medicare announced that its Jadcherla facility in Telangana received a warning letter on 9 October 2020 from the US drug regulator. Shilpa Medicare believes that the warning letter will have minimum impact of disruption of supplies and the existing revenues from operations of this facility.

Trident announced that its bath linen production rose 12.3% to 4,731 metric tons, bed linen production increased 56.4% to 3.8 million metres and yarn production expanded 4.2% to 9,058 metric tons in September 2020 over September 2019.

Powered by Capital Market - Live News

MARKETS
TODAY'S MARKET SECTOR
BSE NSE
Currencies
Currency EUR GBP INR USD
Europe (EUR) 1.00 0.86 90.34 1.08
United Kingdom (GBP) 1.17 1.00 105.32 1.26
India (INR) 0.01 0.01 1.00 0.01
United States (USD) 0.92 0.79 83.33 1.00
Market News << ALL News
  28-Mar-2024, (04:13 )  Bajaj Finance rallie..
  28-Mar-2024, (03:39 )  Salasar Tech-RVNL JV..
  28-Mar-2024, (03:09 )  Bank of Maharashtra ..
  28-Mar-2024, (03:00 )  Camlin Fine Sciences..
 Commodities << ALL Commodities
   Attention Investor: Prevent unauthorized transactions in your trading / Demat account : Update your mobile number / e mail ids with your stock broker / deposit." | "No need to issue cheques by investors while subscribing to IPO.Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor’s account." | "KYC is one time exercise while dealing in securities markets- once KYC is done through a SEBI registered intermediary(broker, DP, Mutual Fund etc.) you need not undergo the same process again when you approach another intermediary."
   Disclaimer   |   BSE Disclosure  |  Privacy Policy   |   Investor Protection   |    Inactive Account   |  Vernacular Language: NSE | BSE   |   Feedback   |    PMLA Policy   |   Risk Management Policy   |   Insider Trading   |   Investor Grivenances   |   Investor Complaints   |   Investor Charter   |   Rules And Regulations   |   Broker Norms   |   Terms of Use    Policies & Procedures   |   Risk Disclosure   |   Do & Don’ts   |   Rights & Obligations
  
SEBI Registration No : INZ000267132   |   BSE Clearing No : 333   
   Copyright © 2011 All rights reserved by Jaysukhlal Jagjivan Stock Broking Pvt.Ltd Designed, Developed & Powered By CMOTS INFOTECH (ISO 9001:2015 certified)